Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Annals of Internal Medicine
|
September 5, 2012
Knot
David J Einstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2018
Compassion and Compassionate Use
David J Einstein
Current Treatment Options in Oncology
|
February 12, 2019
Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer
David J Einstein, Guru Sonpavde
Urology
|
November 2, 2020
Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
Brian Halbert, David J Einstein
Urology
|
August 28, 2019
EDITORIAL COMMENT
Marc B Garnick, David J Einstein
Urology
|
November 10, 2020
EDITORIAL COMMENT
Marc B Garnick, David J Einstein
Urology
|
March 23, 2023
EDITORIAL COMMENT
Daniel Sentana-Lledo, David J Einstein
Clinical Advances in Hematology & Oncology : H&O
|
July 28, 2017
Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancer
David J Einstein, David F McDermott
JAMA Oncology
|
February 26, 2016
The Ethical Imperative of Healthy Paternalism in Advance Directive Discussions at the End of Life
David J Einstein, Keren Ladin, Paul Mathew
JAMA Oncology
|
June 10, 2016
Against "Healthy Paternalism" at the End of Life-Reply
Paul Mathew, David J Einstein, Keren Ladin
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Annals of Internal Medicine
|
September 5, 2012
Knot
David J Einstein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2018
Compassion and Compassionate Use
David J Einstein
Current Treatment Options in Oncology
|
February 12, 2019
Treatment Approaches for Cisplatin-Ineligible Patients with Invasive Bladder Cancer
David J Einstein, Guru Sonpavde
Urology
|
November 2, 2020
Hot or Not: Tumor Mutational Burden (TMB) as a Biomarker of Immunotherapy Response in Genitourinary Cancers
Brian Halbert, David J Einstein
Urology
|
August 28, 2019
EDITORIAL COMMENT
Marc B Garnick, David J Einstein
Urology
|
November 10, 2020
EDITORIAL COMMENT
Marc B Garnick, David J Einstein
Urology
|
March 23, 2023
EDITORIAL COMMENT
Daniel Sentana-Lledo, David J Einstein
Clinical Advances in Hematology & Oncology : H&O
|
July 28, 2017
Combined blockade of vascular endothelial growth factor and programmed death 1 pathways in advanced kidney cancer
David J Einstein, David F McDermott
JAMA Oncology
|
February 26, 2016
The Ethical Imperative of Healthy Paternalism in Advance Directive Discussions at the End of Life
David J Einstein, Keren Ladin, Paul Mathew
JAMA Oncology
|
June 10, 2016
Against "Healthy Paternalism" at the End of Life-Reply
Paul Mathew, David J Einstein, Keren Ladin
Page
of 6